结论：盐酸氨溴索渗透泵控释片释药稳定，零级释药明显，具备优良控释制剂的特征。
Conclusions: The ambroxol HCl osmotic pump controlled release tablets have a stable release curve and conform to zero release order.
我们对渗透泵型控释制剂的研究，从包衣膜和片芯处方两个方面着手。
Our research in osmotic pump formulations will start from two aspects, the core prescription and the coating film.
新剂型“渗透泵控释片剂”生产中的打孔要求是目前该类型制剂的研发瓶颈。
The drilling requirements in the production of a new type troche, osmotic pump control-released tablets, is the nodus in the research of this kind of medicine.
应用推荐